392 related articles for article (PubMed ID: 37405612)
1. Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments.
Zhi F; Zhang Q; Liu L; Chang X; Xu H
Cell Stress Chaperones; 2023 Nov; 28(6):641-655. PubMed ID: 37405612
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial quality control mechanisms as molecular targets in diabetic heart.
Chang X; Li Y; Cai C; Wu F; He J; Zhang Y; Zhong J; Tan Y; Liu R; Zhu H; Zhou H
Metabolism; 2022 Dec; 137():155313. PubMed ID: 36126721
[TBL] [Abstract][Full Text] [Related]
3. Pgam5 aggravates hyperglycemia-induced myocardial dysfunction through disrupting Phb2-dependent mitochondrial dynamics.
Chen Y; Huang J; Zhou H; Lin J; Tao J
Int J Med Sci; 2024; 21(7):1194-1203. PubMed ID: 38818468
[TBL] [Abstract][Full Text] [Related]
4. The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy.
Dabravolski SA; Sadykhov NK; Kartuesov AG; Borisov EE; Sukhorukov VN; Orekhov AN
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887211
[TBL] [Abstract][Full Text] [Related]
5. Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy.
Westermeier F; Navarro-Marquez M; López-Crisosto C; Bravo-Sagua R; Quiroga C; Bustamante M; Verdejo HE; Zalaquett R; Ibacache M; Parra V; Castro PF; Rothermel BA; Hill JA; Lavandero S
Biochim Biophys Acta; 2015 May; 1853(5):1113-8. PubMed ID: 25686534
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies.
Cai C; Wu F; He J; Zhang Y; Shi N; Peng X; Ou Q; Li Z; Jiang X; Zhong J; Tan Y
Int J Biol Sci; 2022; 18(14):5276-5290. PubMed ID: 36147470
[TBL] [Abstract][Full Text] [Related]
7. Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs.
Zhou Y; Suo W; Zhang X; Liang J; Zhao W; Wang Y; Li H; Ni Q
Biomed Pharmacother; 2023 Dec; 168():115669. PubMed ID: 37820568
[TBL] [Abstract][Full Text] [Related]
8. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.
Qi B; He L; Zhao Y; Zhang L; He Y; Li J; Li C; Zhang B; Huang Q; Xing J; Li F; Li Y; Ji L
Diabetologia; 2020 May; 63(5):1072-1087. PubMed ID: 32072193
[TBL] [Abstract][Full Text] [Related]
9. Effect of exercise on improving myocardial mitochondrial function in decreasing diabetic cardiomyopathy.
Zhang F; Lin JJ; Tian HN; Wang J
Exp Physiol; 2024 Feb; 109(2):190-201. PubMed ID: 37845840
[TBL] [Abstract][Full Text] [Related]
10. Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy.
Kubli DA; Gustafsson ÅB
Antioxid Redox Signal; 2015 Jun; 22(17):1527-44. PubMed ID: 25808102
[TBL] [Abstract][Full Text] [Related]
11. SIRT6: A potential therapeutic target for diabetic cardiomyopathy.
Wu T; Qu Y; Xu S; Wang Y; Liu X; Ma D
FASEB J; 2023 Aug; 37(8):e23099. PubMed ID: 37462453
[TBL] [Abstract][Full Text] [Related]
12. SFRP2 Improves Mitochondrial Dynamics and Mitochondrial Biogenesis, Oxidative Stress, and Apoptosis in Diabetic Cardiomyopathy.
Ma T; Huang X; Zheng H; Huang G; Li W; Liu X; Liang J; Cao Y; Hu Y; Huang Y
Oxid Med Cell Longev; 2021; 2021():9265016. PubMed ID: 34790288
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
[TBL] [Abstract][Full Text] [Related]
15. ALDH2 attenuates ischemia and reperfusion injury through regulation of mitochondrial fusion and fission by PI3K/AKT/mTOR pathway in diabetic cardiomyopathy.
Tan X; Chen YF; Zou SY; Wang WJ; Zhang NN; Sun ZY; Xian W; Li XR; Tang B; Wang HJ; Gao Q; Kang PF
Free Radic Biol Med; 2023 Feb; 195():219-230. PubMed ID: 36587924
[TBL] [Abstract][Full Text] [Related]
16. Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting Parkin-dependent mitophagy.
Wang S; Zhao Z; Fan Y; Zhang M; Feng X; Lin J; Hu J; Cheng Z; Sun C; Liu T; Xiong Z; Yang Z; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1905-1914. PubMed ID: 29674007
[TBL] [Abstract][Full Text] [Related]
17. The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Oct; 245():236-244. PubMed ID: 28781146
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
19. Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: Role of SIRT6.
Yu LM; Dong X; Xue XD; Xu S; Zhang X; Xu YL; Wang ZS; Wang Y; Gao H; Liang YX; Yang Y; Wang HS
J Pineal Res; 2021 Jan; 70(1):e12698. PubMed ID: 33016468
[TBL] [Abstract][Full Text] [Related]
20. Reduced reticulum-mitochondria Ca
Dia M; Gomez L; Thibault H; Tessier N; Leon C; Chouabe C; Ducreux S; Gallo-Bona N; Tubbs E; Bendridi N; Chanon S; Leray A; Belmudes L; Couté Y; Kurdi M; Ovize M; Rieusset J; Paillard M
Basic Res Cardiol; 2020 Nov; 115(6):74. PubMed ID: 33258101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
